Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 15, 325-328, June 1, 1955]
© 1955 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernard, L. J.
Right arrow Articles by Radakovich, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernard, L. J.
Right arrow Articles by Radakovich, M.

The Effect of Thorium Dioxide (Thorotrast) on Metastases of the Walker Carcinoma 256 and the Relation of Tumor Size to Frequency of Metastases*

Louis J. Bernard{dagger}, Arthur M. Dutton{ddagger} and Michael Radakovich

( Division of Cancer Research, Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, N.Y.)

Male Sprague-Dawley rats of the same age and weight were given inoculations intradermally or subcutaneously of an emulsion of Walker carcinoma 256. All animals of a series received the same initial dose of inoculum. Forty-eight hours later one-half the animals were given intravenous injections of Thorotrast into the tail vein. At 30 days the animals were sacrificed by decapitation, and a careful search for metastases to the soft tissues was conducted on each animal. Findings were as follows:

1. Thorotrast had no effect on the incidence of tumor takes, on the final size attained by the tumors in 30 days, or on the incidence of metastases to the regional nodes, lungs, or other tissues.
2. Tumor implants of the same age and arising from the same dose of inoculum varied widely in final size. The incidence of regional and distant metastases correlated well with final tumor size at 30 days.

* This study was supported by a grant from the Anna Fuller Fund.

{dagger} Public Health Service Research Fellow of the National Cancer Institute.

{ddagger} Statistics Section, Atomic Energy Project.

Received 2/11/55.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1955 by the American Association for Cancer Research.